Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8965241 | 0.92 | HSP90AA1 (0.65) | CA12CA1CA9POLBCA2 | |
| SCHEMBL11478927 | 0.85 | CA12 (0.67) | CA12CA1CA9POLBCA2 | |
| SCHEMBL24641959 | 0.84 | ALDH1A1 (0.53) | CA12CA1CA9ALDH1A1KMT2A | |
| SCHEMBL4685693 | 0.83 | CA12 (0.53) | CA12CA1CA9POLBCA2 | |
| SCHEMBL572883 | 0.74 | KMT2A (0.83) | CA12CA1CA9POLBCA2 | |
| SCHEMBL12321793 | 0.74 | HSP90AA1 (0.84) | HSP90AA1ALDH1A1LMNAMAPK1 | |
| SCHEMBL3780616 | 0.74 | LMNA (0.67) | CA12CA1CA9POLBCA2 | |
| SCHEMBL28503117 | 0.74 | FAAH (0.58) | CA12CA1CA9POLBCA2 | |
| SCHEMBL6140745 | 0.74 | CA12 (0.59) | CA12CA1CA9POLBCA2 | |
| SCHEMBL1949985 | 0.74 | LMNA (0.64) | CA12CA1CA9POLBCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11643522-B2 | Polymer composition containing diarylamine-based compound | ZEON CORPORATION (JP) | 2023-05-09 | — | — | US | disclosed |
| EP-3590923-B1 | DIARYLAMINE-BASED COMPOUND, ANTI-AGING AGENT, AND POLYMER COMPOSITION | ZEON CORP (JP) | 2022-08-03 | — | — | EP | disclosed |
| US-20220127430-A1 | POLYMER COMPOSITION CONTAINING DIARYLAMINE-BASED COMPOUND | ZEON CORPORATION (JP) | 2022-04-28 | — | — | US | disclosed |
| US-11254802-B2 | Diarylamine-based compound, anti-aging agent, and polymer composition | ZEON CORPORATION (JP) | 2022-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127430-A1 | POLYMER COMPOSITION CONTAINING DIARYLAMINE-BASED COMPOUND | GPX1, GPX4, GSTA1 | CA12 2223/4885CA1 2483/4885CA9 2754/4885 |
| US-11643522-B2 | Polymer composition containing diarylamine-based compound | GPX1, GPX4, GSTA1 | CA12 2223/4885CA1 2483/4885CA9 2754/4885 |
| US-11254802-B2 | Diarylamine-based compound, anti-aging agent, and polymer composition | CCNA1, CCNA2, CDKN1A | CA12 4273/4885CA1 3973/4885CA9 3130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.